NTC Reports Successful Phase II Study of New Treatment for Bacterial Conjunctivitis NTC announces promising outcomes from its Phase II MIRAKLE clinical trial for NTC014, a novel treatment for bacterial conjunctivitis, demonstrating effective use with less antibiotics.

NTC Reports Successful Phase II Study of New Treatment for Bacterial Conjunctivitis #Italy #Milan #NTC014 #Mirakle_study #conjunctivitis

Innovative Phase II Study Mirakle Shows Promising Results for Bacterial Conjunctivitis Treatment NTC's Phase II Mirakle study reveals positive outcomes for an innovative eye drop treatment for bacterial conjunctivitis in adults. Find out more!

Innovative Phase II Study Mirakle Shows Promising Results for Bacterial Conjunctivitis Treatment #Italy #Milan #NTC014 #bacterial_conjunctivitis #Mirakle_study